Product Details
Aldara 5% Cream – Imiquimod 5% Topical Treatment
Aldara 5% Cream is a topical dermatological medicine containing Imiquimod 5% as its active ingredient. It belongs to a group of medicines known as immune response modifiers. It works by stimulating the local immune system to help the body respond to certain abnormal skin conditions.
Aldara is used for specific skin conditions under medical supervision. It is not an ordinary cosmetic cream or general-purpose skin whitening product.
Active Ingredient
Imiquimod: 5%
Product Form: Topical Cream
Strength: 5%
Product Category: Dermatological Medicine
Uses of Aldara 5% Cream
Aldara 5% Cream may be prescribed for the following conditions:
1. External Genital Warts
Used for certain external genital and perianal warts in eligible adults.
2. Actinic Keratosis
Prescribed for certain precancerous skin lesions caused by long-term sun exposure.
3. Superficial Basal Cell Carcinoma
Used for selected cases of superficial basal cell carcinoma when appropriate for the patient.
How Does Aldara 5% Cream Work?
Imiquimod stimulates the local immune response in the skin. It helps activate immune signalling pathways that encourage the body to respond to abnormal skin cells and certain viral skin lesions.
Important Precautions
Use only with a doctor's prescription.
Apply only to the affected area as directed.
Avoid contact with eyes, mouth and other unintended areas.
Do not apply to broken or irritated skin unless directed by your doctor.
Wash hands before and after application.
Skin redness, itching, burning, swelling and irritation may occur.
Avoid sexual contact while the cream is present on treated genital areas.
Do not use during pregnancy or breastfeeding without medical advice.
Consult your doctor if you experience severe skin reactions.
How to Use Aldara 5% Cream
The application schedule depends on the condition being treated.
For external genital warts, a commonly prescribed schedule is three times weekly.
For actinic keratosis, treatment schedules may vary, commonly involving two applications weekly.
For superficial basal cell carcinoma, a commonly prescribed schedule is five applications weekly.